Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

GP, I also feel your frustration and I agree the company is struggling based on what Brettj has reported. If the rumor that PN will not even speak with highly placed individuals from the Cancer Moonshot Program is true, we have to question why. If institutional investors know this rumor is true our Board's judgment has to be questioned.

IMO the other factors delaying the PPS increase are the "unholy trinity" of PN holding the COB, CEO and CFO positions. This is bush league. The checks and balances required in a normally company do not exist here. IMO there is no independent BOD member which further compounds the problem. If I knew the company were to retain this start up type of structure at this stage in the game, most likely I would have never invested in BPTH.

The inability of the company to provide updates regarding the combination therapy trial suggests to me there has been no progress. Based on this companies past history I would be surprised if more than the original patient announced by the company has been fully dosed. This company does not seem to understand the urgency created by the present burn rate. With administrative costs running at least $1 million per quarter time is running out. I would have expected the company to be close to dosing 10 to 15 patients by now. I now realize my expectations were simply "pipe dreams."